Bioactivity:

BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor.�BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.�Administration of BMS-P5 to multiple myeloma-bearing mice

CAS nr:

1550371-22-6

Purity:

98%

Molecular Weight:

472,58

SMILES:

O=C(N1[C@@H](C)CC[C@@H](N)C1)C2=CC(OC)=C3C(N=C(C4=CC5=CC=CN=C5N4CC6CC6)N3C)=C2

Formula:

C27H32N6O2

Pathway:

Chromatin/Epigenetic

Target:

PAD